Abstract
BackgroundIncreased levels of tumor-infiltrating lymphocytes (TILs) are associated with improved survival in patients with cancer. Anti–PD-1/PD-L1–based cancer immunotherapies have revolutionized the treatment of cancers, and TIL abundance can be used...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
